Impacts of regulated competition on pricing in Chinese pharmaceutical market under urban employee basic medical insurance

References

• Pavenik N. Do pharmaceutical prices respond to potential patient out-of-pocket expenses? Rand J Econ. 2002;33(3):469–487.
   PubMed Web of Science ®Google Scholar
• Ekelund M, Persson B. Pharmaceutical pricing in a regulated market. Rev Econ Stat. 2003;85(2):298–306.
   Web of Science ®Google Scholar
• Dalen DM, Strom S, Haabeth T. Price regulation and generic competition in the pharmaceutical market. Eur J Health Econ. 2006;7(3):204–211.
   Google Scholar
• Ellison SF, Snyder CM. Countervailing power in wholesale pharmaceuticals. J Ind Econ. 2001;58(1):32–53.
   Google Scholar
• Eichler HG, Hurts H, Broich K, et al. Drug regulation and pricing – can regulators influence affordability? New Engl J Med. 2016;374(19):1807–1809.
   PubMed Web of Science ®Google Scholar
• Santerre RE, Vernon JA. Assessing consumer gains from a drug price control policy in the United States. South Econ J. 2006;73(1):233–245.
   Web of Science ®Google Scholar
• Chen Y, Schweitzer SO. Issues in drug pricing, reimbursement, and access in China with references to other Asia-Pacific region. Value Health. 2008;11(Suppl 1):S124–S9.
   PubMed Web of Science ®Google Scholar
• Danzon PM, Chao LW. Does regulation drive out competition in pharmaceutical markets? J Law Econ. 2000;43(2):311–357.
   Web of Science ®Google Scholar
• Wang LJ, Ge JH. Background and evolution of hospital pharmaceuticals group procurement scheme [in Chinese]. Chin J Health Policy. 2009;12:8–13.
   Google Scholar
• National Development and Reform Commission (NDRC). Opinions of promoting drug price reform [in Chinese]. Beijing: NDRC; 2015.
   Google Scholar
• Grabowski HG, Vernon JM. Brand loyalty, entry, and price competition in pharmaceutical after the 1984 drug act. J Law Econ. 1992;35(2):331–350.
   Web of Science ®Google Scholar
• Frank RG, Salkever DS. Generic entry and the pricing of pharmaceuticals. J Econ Manage Strat. 1997;6(1):75–90.
   Web of Science ®Google Scholar
• Lu ZJ, Comanor WS. Strategic pricing of new pharmaceuticals. Rev Econ Stat. 1998;80:108–118.
   Web of Science ®Google Scholar
• Danzon PM, Mulcahy AW, Towse AK. Pharmaceutical pricing in emerging markets: effects of income, competition, and procurement. Health Econ. 2015;24(2):238–252.
   PubMed Web of Science ®Google Scholar
• Liu YM, Yang YH, Hsieh CR. Regulation and competition in the Taiwanese pharmaceutical market under national health insurance. J Health Econ. 2012;31(3):471–483.
   PubMed Web of Science ®Google Scholar
• Wang YR. Price competition in the Chinese pharmaceutical market. Int J Health Care Fi. 2006;6(2):119–129.
   Google Scholar
• Wu J, Xu J, Liu G, et al. Pharmaceutical pricing: an empirical study of market competition in Chinese hospitals. Pharmacoeconomics. 2014;32(3):293–303.
   PubMed Web of Science ®Google Scholar
• Pan H, Luo H, Chen S, et al. Pharmacopoeial quality of antimicrobial drugs in southern China. The Lancet Global Health. 2016;4(5):e300–e2.
   PubMed Web of Science ®Google Scholar
• State Council of P.R. China. 12th five-year plan for drug safety (2011–2015) [in Chinese]. Beijing: State Council of P.R. China; 2012.
   Google Scholar
• State Development Planning Commission. The method of government drug pricing [in Chinese]. Beijing: SDPC; 2000.
   Google Scholar
• Ngorsuraches S, Meng W, Kim BY, et al. Drug reimbursement decision-making in Thailand, China, and South Korea. Value Health. 2012;15(Suppl 1):S120–S5.
   PubMed Web of Science ®Google Scholar
• Guo L. The causes and solutions of problems in drug price management in China [in Chinese]. Contemp Economy Manag. 2013;35(4):21–25.
   Google Scholar
• State Council of P.R. China. Implementation plan for the recent priorities of the health care system reform (2009-2011) [in Chinese]. Beijing: State Council of P.R. China; 2009.
   Google Scholar
• Anis AH, Guh DP, Woolcott J. Lowering generic drug prices: less regulation equals more competition. Med Care. 2003;41(1):135–141.
   PubMed Web of Science ®Google Scholar
• Puig-Junoy J. Impact of European pharmaceutical price regulation on generic price competition: a review. Pharmacoeconomics. 2010;28(8):649–663.
   PubMed Web of Science ®Google Scholar
• Wan Y, Liu B. Comparative study on the differences between the maximum retail price and purchasing tender price of original and generic drugs [in Chinese]. China Pharmacy. 2015;26(15):2032–2034.
   Google Scholar
• National Bureau of Statistics of the P.R. of China. The key data on the sixth national census bulletin of the National Bureau of Statistics in Tianjin [in Chinese]. Beijing: National Bureau of Statistics of the P.R. of China; 2012. cited 2015 Nov 14. Available from http://www.stats.gov.cn/tjsj/tjgb/rkpcgb/dfrkpcgb/201202/t20120228_30405.html
   Google Scholar
• Southern Medicine Economic Research Institute. Blue book on the development of Chinese medical and pharmaceutical market in 2014: part of medical terminal (II) [in Chinese]. Progress in Pharmaceutical Science. 2014;38(7):481–496.
   Google Scholar
• Southern Medicine Economic Research Institute. Top 100 enterprises in Chinese pharmaceutical industry [in Chinese]. Guangzhou; 2009 Apr 16.Medical Economic News; p. F23.
   Google Scholar
• Danzon PM, Chao LW. Cross-national price differences for pharmaceuticals: how large, and why? J Health Econ. 2000;19(2):159–195.
   PubMed Web of Science ®Google Scholar
• Ding JX, Zhao Y. Innovative drug “independent pricing policy” quantitative analysis [in Chinese]. China Pharmaceuticals. 2011;20(24):1–4.
   Google Scholar
• Rizzo JA, Zeckhauser R. Generic script share and the price of brand-name drugs: the role of consumer choice. Int J Health Care Finance Econ. 2009;9(3):291–316.
   PubMedGoogle Scholar
• Caves RE, Temin P. Patent expiration, entry and competition in the U.S. pharmaceutical industry. Brookings papers on economic activity. Microeconomics. 1991;1–66.
   Google Scholar
• Wiggins SN, Robert M. Price competition in pharmaceuticals: the case of anti-infectives. Economic Inquiry. 2004;42(2):247–263.
   Web of Science ®Google Scholar
• Frank RG, Salkever DS. Pricing, patent loss and the market for pharmaceuticals. South Econ J. 1992;59:165–179.
   Web of Science ®Google Scholar
• Dylst P, Simoens S. Does the market share of generic medicines influence the price level? A European analysis. Pharmacoeconomics. 2011;29(10):875–882.
   PubMed Web of Science ®Google Scholar
• Griliches Z, Cockburn I. Generics and new goods in pharmaceutical price indexes. Am Econ Rev. 1994;84(5):1213–1232.
   Web of Science ®Google Scholar
• Berndt ER, Aitken ML Brand loyalty, generic entry and price competition in pharmaceuticals in the quarter century after the 1984 Waxman-Hatch Legislation. NBER Working Paper. 2010; 16431.
   Google Scholar